Advances in carbon nanomaterials for immunotherapy
Source abstract
Abstract
Remarkable advances have been achieved in the field of nanomedicine and immunotherapy, since it was found that several nanomaterials can modulate the immune system. The main objective of this review is to collect and discuss studies where carbon nanomaterials (CNM), due to their unique structure and composition, revealed to be important tools in cancer treatment, immunostimulation, and immunosuppression of inflammatory or autoimmune diseases. These materials offer several advantages, such as being effective platforms for drug delivery and targeting, immunomodulation, phototherapy, and others. Some effects still need to be upgraded and some questions persist. Positive results were already achieved, although translation to clinics is still needed. The evolution of future investigations may still revolutionize the field of biomedicine.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics · Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Cancer immunotherapy10.1002/biot.200500044 ↗
2. International consensus on allergy immunotherapy10.1016/j.jaci.2015.04.047 ↗
3. Design of effective immunotherapy for human autoimmunity10.1038/nature03727 ↗
4. Tolerogenic dendritic cells on transplantation: immunotherapy based on second signal blockage10.1155/2015/856707 ↗
5. Principles of immunotherapy: implications for treatment strategies in cancer and infectious diseases10.3389/fmicb.2018.03158 ↗
6. Nanomaterials for direct and indirect immunomodulation: A review of applications10.1016/j.ejps.2019.105139 ↗
7. Mechanisms of immunomodulation by drugs10.1177/019262338701500312 ↗
8. Biological responses to physicochemical properties of biomaterial surface10.1039/D0CS00103A ↗
9. How do cytotoxic lymphocytes kill cancer cells?10.1158/1078-0432.CCR-15-0685 ↗
10. The safety and tolerability of combined immune checkpoint inhibitors (anti-PD-1/PD-L1 plus anti-CTLA-4): a systematic review and meta-analysis10.1186/s12885-019-5785-z ↗
11. Interactions of nanomaterials with the immune system
12. Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases10.1093/intimm/dxz021 ↗
13. Impact of carbon nanotubes and graphene on immune cells10.1186/1479-5876-12-138 ↗
14. Minireview: nanoparticles and the immune system10.1210/en.2009-1082 ↗
15. Immune system targeting by biodegradable nanoparticles for cancer vaccines10.1016/j.jconrel.2013.03.010 ↗
16. Molecular and immunological toxic effects of nanoparticles10.1016/j.ijbiomac.2017.09.110 ↗
17. Graphene-based materials biocompatibility: a review10.1016/j.colsurfb.2013.05.022 ↗
18. Immunomodulation of nanoparticles in nanomedicine applications10.1155/2014/426028 ↗
19. Materials engineering for immunomodulation10.1038/nature08604 ↗
20. Cytokines as biomarkers of nanoparticle immunotoxicity10.1039/c3cs60064e ↗
21. Immunotoxicity of poly (lactic-co-glycolic acid) nanoparticles: influence of surface properties on dendritic cell activation10.1080/17435390.2018.1564078 ↗
22. Micro and nano material carriers for immunomodulation10.1111/ajt.13878 ↗
23. Safety assessment of graphene-based materials: focus on human health and the environment10.1021/acsnano.8b04758 ↗
24. The biodegradation of fullerene C 60 by myeloperoxidase
25. Effects of oxidation by hydrogen peroxide on the structures of multiwalled carbon nanotubes10.1021/ie0604627 ↗
26. Carbon nanomaterials as new tools for immunotherapeutic applications10.1039/C4TB00563E ↗
27. Recent advances in carbon nanomaterials for cancer phototherapy10.1002/chem.201804383 ↗
28. Opportunities and challenges of carbon-based nanomaterials for cancer therapy10.1517/17425247.5.3.331 ↗
29. Application of nanomaterials in cancer immunotherapy10.1016/j.mtchem.2018.01.001 ↗
30. Nanomaterials-Mediated Immunomodulation for Cancer Therapeutics10.3389/fchem.2021.629635 ↗
31. Self-targeting nanotherapy based on functionalized graphene oxide for synergistic thermochemotherapy10.1016/j.jcis.2021.06.072 ↗
32. Engineering immunological tolerance using quantum dots to tune the density of self‐antigen display10.1002/adfm.201700290 ↗
33. Designing inorganic nanomaterials for vaccines and immunotherapies10.1016/j.nantod.2019.04.005 ↗
34. C.W. Shields IV, L.L.W. Wang, M.A. Evans, S.J.A.M. Mitragotri, 32 (2020) 1901633.10.1002/adma.201901633 ↗
35. Nanoparticle‐based nanomedicines to promote cancer immunotherapy: Recent advances and future directions10.1002/smll.201900262 ↗
36. Improving cancer immunotherapy through nanotechnology10.1038/s41568-019-0186-9 ↗
37. A review of shaped carbon nanomaterials10.4102/sajs.v107i3/4.418 ↗
38. Biomaterials Science: An Introduction to Materials in Medicine
39. The biocompatibility of carbon nanotubes10.1016/j.carbon.2005.10.011 ↗
40. Making carbon nanotubes biocompatible and biodegradable10.1039/c1cc13011k ↗
41. Antibacterial effects of carbon nanotubes: size does matter!10.1021/la800951v ↗
42. Graphene and the immune system: Challenges and potentiality10.1016/j.addr.2016.05.014 ↗
43. Graphene Oxide Topical Administration: Skin Permeability Studies10.3390/ma14112810 ↗
44. Smaller particle size and higher oxidation improves biocompatibility of graphene-based materials10.1016/j.carbon.2015.11.076 ↗
45. Highly efficient cascading synergy of cancer photo-immunotherapy enabled by engineered graphene quantum dots/photosensitizer/CpG oligonucleotides hybrid nanotheranostics10.1016/j.biomaterials.2019.03.020 ↗
46. Graphene quantum dots for theranostics and bioimaging10.1007/s11095-016-1937-x ↗
47. Graphene quantum dots for cancer targeted drug delivery10.1016/j.ijpharm.2016.12.060 ↗
48. Applications of nanotechnology for immunology10.1038/nri3488 ↗
49. Anti-inflammatory effect of fullerene C 60 in a mice model of atopic dermatitis10.1186/s12951-016-0159-z ↗
50. Biological applications of fullerenes10.1016/0968-0896(96)00081-8 ↗
51. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods10.1002/ijc.31937 ↗
52. Side effects and emotional distress during cancer chemotherapy10.1002/1097-0142(19890201)63:3<604::AID-CNCR2820630334>3.0.CO;2-2 ↗
53. Cardiac side-effects from breast cancer radiotherapy10.1016/j.clon.2015.06.007 ↗
54. Cancer immunotherapy: the beginning of the end of cancer?10.1186/s12916-016-0623-5 ↗
55. Delivery technologies for cancer immunotherapy10.1038/s41573-018-0006-z ↗
56. Cytokines in the treatment of cancer10.1089/jir.2018.0019 ↗
57. CAR‐T cell therapy in melanoma: A future success story?10.1111/exd.13792 ↗
58. Photothermal therapy promotes tumor infiltration and antitumor activity of CAR T cells
59. Cancer immunotherapy: Pros, cons and beyond10.1016/j.biopha.2020.109821 ↗
60. Advantages and clinical applications of natural killer cells in cancer immunotherapy10.1007/s00262-013-1469-8 ↗
61. Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapy10.1016/j.biomaterials.2016.07.005 ↗
62. A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
63. Macrophage targeting: opening new possibilities for cancer immunotherapy10.1111/imm.12976 ↗
64. First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers10.1016/j.ymthe.2020.11.002 ↗
65. Predicting clinical benefit of immunotherapy by antigenic or functional mutations affecting tumour immunogenicity
66. Biomaterials for vaccine-based cancer immunotherapy10.1016/j.jconrel.2018.10.008 ↗
67. Near-Infrared Radiation-Based Mild Photohyperthermia Therapy of Non-Melanoma Skin Cancer with PEGylated Reduced Nanographene Oxide10.3390/polym12081840 ↗
68. Integrated molecular targeting of IGF1R and HER2 surface receptors and destruction of breast cancer cells using single wall carbon nanotubes10.1088/0957-4484/18/31/315101 ↗
69. Protected Amino Acid–Based Hydrogels Incorporating Carbon Nanomaterials for Near-Infrared Irradiation-Triggered Drug Release10.1021/acsami.9b02482 ↗
70. Thermosensitive hydrogel loaded with chitosan-carbon nanotubes for near infrared light triggered drug delivery
71. High performance in vivo near-IR (> 1 μm) imaging and photothermal cancer therapy with carbon nanotubes10.1007/s12274-010-0045-1 ↗
72. Mitochondria-targeted fluorescent carbon nano-platform for NIR-triggered hyperthermia and mitochondrial inhibition10.1016/j.jiec.2017.06.053 ↗
73. In Vitro Hyperthermia Evaluation of Electrospun Polymer Composite Fibers Loaded with Reduced Graphene Oxide10.3390/polym12112663 ↗
74. Effect of PEG functionalized carbon nanotubes on the enhancement of thermal and physical properties of nanofluids10.1016/j.expthermflusci.2017.02.018 ↗
75. Nanomaterials for cancer immunotherapy10.1016/j.biomaterials.2017.09.017 ↗
76. Effect of partial PEGylation on particle uptake by macrophages10.1039/C6NR07353K ↗
77. Augmentation of EPR effect and efficacy of anticancer nanomedicine by carbon monoxide generating agents10.3390/pharmaceutics11070343 ↗
78. Nanomaterials for cancer therapy and imaging10.1007/s10059-011-0051-5 ↗
79. Carbon nanomaterials for targeted cancer therapy drugs: A critical review10.1002/tcr.201800038 ↗
80. Cancer targeting and drug delivery using carbon-based quantum dots and nanotubes10.3390/molecules23020378 ↗
81. urface chemistry of carbon nanoparticles functionally select their uptake in various stages of cancer cells10.1007/s12274-017-1518-2 ↗
82. Engineered Nanoparticles for Cancer Vaccination and Immunotherapy10.1021/acs.accounts.0c00456 ↗
83. Functional nanomaterials can optimize the efficacy of vaccines10.1002/smll.201401707 ↗
84. Single-walled carbon nanotubes deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigens10.1021/nn200182x ↗
85. Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunity10.1158/1078-0432.CCR-10-2444 ↗
86. Enhanced cellular activation with single walled carbon nanotube bundles presenting antibody stimuli10.1021/nl080332i ↗
87. Clustering of stimuli on single-walled carbon nanotube bundles enhances cellular activation10.1021/la902068z ↗
88. Adsorption of Multimeric T Cell Antigens on Carbon Nanotubes: Effect on Protein Structure and Antigen‐Specific T Cell Stimulation10.1002/smll.201201684 ↗
89. Carbon nanotubes conjugated to tumor lysate protein enhance the efficacy of an antitumor immunotherapy10.1002/smll.200701059 ↗
90. Subcutaneous injection of water-soluble multi-walled carbon nanotubes in tumor-bearing mice boosts the host immune activity10.1088/0957-4484/21/14/145104 ↗
91. Effective colon cancer prophylaxis in mice using embryonic stem cells and carbon nanotubes10.2147/IJN.S24060 ↗
92. Immunomodulatory effects of carbon nanotubes functionalized with a Toll-like receptor 7 agonist on human dendritic cells10.1016/j.carbon.2013.09.090 ↗
93. Engineered fluorescent carbon dots as promising immune adjuvants to efficiently enhance cancer immunotherapy10.1039/C8NR07252C ↗
94. Cancer Immunotherapy Based on Carbon-Quantum-Dots
95. pH-Sensitive carbon dots for enhancing photomediated antitumor immunity10.1021/acs.molpharmaceut.0c00227 ↗
96. Polarization and function of tumor-associated macrophages mediate graphene oxide-induced photothermal cancer therapy10.1016/j.jphotobiol.2020.111913 ↗
97. Functionalized graphene oxide serves as a novel vaccine nano-adjuvant for robust stimulation of cellular immunity10.1039/C5NR09208F ↗
98. Alum-functionalized graphene oxide nanocomplexes for effective anticancer vaccination10.1016/j.actbio.2018.11.023 ↗
99. Exploration of graphene oxide as an intelligent platform for cancer vaccines10.1039/C5NR04986E ↗
100. Differential immunomodulatory effect of graphene oxide and vanillin-functionalized graphene oxide nanoparticles in human acute monocytic leukemia cell line (THP-1)10.3390/ijms20020247 ↗